Gilead’s remdesivir rescued from ‘scrapheap’ by taxpayers, who deserve a better price: lawmaker esagonowsky Wed, 07/15/2020 – 09:39

AstraZeneca re-ups with fitness guru—and Brilinta user—Bob Harper to build out heart attack survivors community beth.bulik Wed, 07/15/2020 […]

Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving an FDA-approved drug normally given for rheumatoid […]

Novartis’ Entresto gains steam with cardiologists despite stinging heart failure trial flop kblankenship Wed, 07/15/2020 – 08:10

A study from Ann & Robert H. Lurie Children’s Hospital of Chicago found that children with a MED-EL […]

An open-access American Journal of Roentgenology (AJR) article investigating the differences in CT findings between coronavirus disease (COVID-19) […]

The Professional Standards Authority (PSA) is to review the accreditation of the Society of Homoeopaths after the society’s […]

Anderson and colleagues discuss the need to mitigate the longer term effects of the covid-19 pandemic in an […]

The findings provide a baseline for further research into how the virus is spreading in England

If approved, belantamab mafodotin will be a first-in-class anti-BCMA therapy for relapsed/refractory multiple myeloma